Australia's most trusted
source of pharma news
Wednesday, 30 April 2025
Posted 28 April 2025 AM
The PBAC has recommended just under three-quarters of all submissions considered at its controversial March meeting - but some big names are among those that missed out this time around.
Overall, the committee recommended 23 out of 35 new PBS listing submissions and 10 out of 11 change to existing listing submissions.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.